Finance

Beta
Lists
531015:BOM
Venmax Drugs and Pharmaticals Ltd
₹20.10
+1.16%
(+0.23) 1D
Jun 19, 3:30:00 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for 531015...
Open
₹20.07
High
₹20.98
Low
₹19.71
Mkt. cap
233.74M
Avg. vol.
2.76K
Volume
4.06K
P/E ratio
95.71
52-wk high
₹36.96
52-wk low
₹19.01
EPS
₹0.21
No. of employees
2
Open
₹20.07
High
₹20.98
Low
₹19.71
Mkt. cap
233.74M
Avg. vol.
2.76K
Volume
4.06K
P/E ratio
95.71
52-wk high
₹36.96
52-wk low
₹19.01
EPS
₹0.21
No. of employees
2
News stories
From sources across the web
About Venmax Drugs and Pharmaticals Ltd
CEO-
Employees2
Founded1988
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in INR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in INR
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
12.10M
13.18M
15.52M
39.44M
Cost of goods sold
10.91M
11.44M
14.10M
36.36M
Cost of revenue
10.91M
11.44M
14.10M
36.36M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
465.00K
612.00K
347.00K
543.00K
Operating expense
821.00K
1.28M
1.67M
2.96M
Total operating expenses
11.73M
12.73M
15.78M
39.32M
Operating income
375.00K
458.00K
-253.00K
122.00K
Other non operating income
-
-300.00
682.00K
922.00K
EBT including unusual items
374.00K
451.70K
429.00K
1.04M
EBT excluding unusual items
374.00K
451.70K
429.00K
1.04M
Income tax expense
-
207.70K
108.00K
-28.00K
Effective tax rate
-
45.98%
25.17%
-2.68%
Other operating expenses
346.00K
661.00K
1.32M
2.40M
Net income
374.00K
244.00K
321.00K
1.07M
Net profit margin
3.09%
1.85%
2.07%
2.72%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-1.00K
-6.00K
-
-
Net interest expenses
-1.00K
-6.00K
-
-
Depreciation and amortization charges
10.00K
10.00K
10.00K
10.00K
EBITDA
385.00K
468.00K
-243.00K
132.00K
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more